[go: up one dir, main page]

DK200801818A - Vaccine antigens from piscirickettsia salmonis - Google Patents

Vaccine antigens from piscirickettsia salmonis Download PDF

Info

Publication number
DK200801818A
DK200801818A DK200801818A DKPA200801818A DK200801818A DK 200801818 A DK200801818 A DK 200801818A DK 200801818 A DK200801818 A DK 200801818A DK PA200801818 A DKPA200801818 A DK PA200801818A DK 200801818 A DK200801818 A DK 200801818A
Authority
DK
Denmark
Prior art keywords
protein
seq
amino acid
vaccine
group
Prior art date
Application number
DK200801818A
Other languages
Danish (da)
English (en)
Inventor
Kirke David Francis
Francis Michael James
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of DK200801818A publication Critical patent/DK200801818A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1246—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Rickettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK200801818A 2007-12-19 2008-12-19 Vaccine antigens from piscirickettsia salmonis DK200801818A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1478207P 2007-12-19 2007-12-19
US1478207 2007-12-19

Publications (1)

Publication Number Publication Date
DK200801818A true DK200801818A (en) 2009-06-20

Family

ID=40471541

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200801818A DK200801818A (en) 2007-12-19 2008-12-19 Vaccine antigens from piscirickettsia salmonis

Country Status (6)

Country Link
US (2) US7811583B2 (fr)
EP (1) EP2231698B9 (fr)
AU (1) AU2008337440B2 (fr)
CA (1) CA2708167C (fr)
DK (1) DK200801818A (fr)
WO (1) WO2009077577A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0312632B1 (pt) * 2002-07-15 2014-09-16 Novartis Ag Uso de células vivas e mortas de Arthrobacter contra septicemia rickettsiácea em salmonídeos, composição de vacina e kit, e uso dos mesmos
EP2950816B1 (fr) 2013-02-04 2019-07-31 Schweitzer Biotech Company Ltd. Utilisation de séquences d'adn codant pour un interféron en tant qu'adjuvants de vaccin
CN103110583A (zh) * 2013-03-05 2013-05-22 西南民族大学 一种绵羊肺炎支原体灭活疫苗的制备工艺
WO2014198913A2 (fr) * 2013-06-14 2014-12-18 Cermaq As Nouvel isolat de piscirickettsia salmonis
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
CA2968602A1 (fr) * 2014-11-24 2016-06-02 Pontificia Universidad Catolica Del Valparaiso Milieu de culture permettant la croissance de la bacterie piscirickettsia salmonis
NO20200827A1 (en) * 2017-12-26 2020-07-14 Univ Chile Vaccine formulation for fish based on lipid nanovesicles,particularly a proteoliposome or cochleate, with activity against the salmonid rickettsial syndrome (srs)
WO2021247715A2 (fr) * 2020-06-03 2021-12-09 The Regents Of The University Of California Antigènes immunogènes de francisella et leur utilisation dans l'immunisation de poissons contre la francisellose
CN117625557B (zh) * 2023-11-23 2024-09-27 中国水产科学研究院珠江水产研究所 一株大口黑鲈（Micropterus salmoides）蛙虹彩病毒（Ranavirus sp.）及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus
DK0712926T3 (da) 1994-10-18 2004-02-09 Akzo Nobel Nv Virus, der forårsager bugspytkirtelsygdom hos fisk
US20040086524A1 (en) 1999-09-17 2004-05-06 Kuzyk Michael A. Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy
NO329958B1 (no) 1999-09-17 2011-01-31 Pfizer Canada Inc Anvendelse av en immunogen mengde av OspA-lipoprotein fra Piscirickettsia salmonis, OspA-antigen, og immunogene promiskuose TCE i et OspA-kimaert fusjonsprotein, for fremstilling av medikamenter, og immunologisk in vitro-fremgangsmate for deteksjon av humoralt antistoff mot OspA eller P. salmonis.
WO2001049712A2 (fr) 2000-01-07 2001-07-12 Akzo Nobel N.V. Vaccin destine a la prevention et/ou la prophylaxie de l'anemie infectieuse du saumon chez des poissons
EP1282710B1 (fr) 2000-03-11 2008-03-05 Novartis AG Vaccin contre la piscirickettsia salmonis destine aux poissons
ES2395524T3 (es) 2000-08-22 2013-02-13 Agensys, Inc. Acido nucleico y proteina correspondiente denominada 158P1D7 util para el tratamiento y la detección del cancer de vejiga y otros canceres
DE60143810D1 (de) 2000-11-11 2011-02-17 Univ Aberdeen Vakzine gegen ipnv die aus hefezellen isoliert werden
US6936256B2 (en) 2001-08-10 2005-08-30 University Of Maryland Biotechnology Institute Sub-unit vaccine for infectious pancreatic necrosis virus
CA2381708C (fr) 2001-08-27 2011-10-18 Universidad Catolica De Valparaiso Proteine immunogenique contre l'infection par piscirickettsia salmonis
BR0312632B1 (pt) 2002-07-15 2014-09-16 Novartis Ag Uso de células vivas e mortas de Arthrobacter contra septicemia rickettsiácea em salmonídeos, composição de vacina e kit, e uso dos mesmos
CA2541464C (fr) 2003-10-07 2016-02-09 Michel Thiry Antigenes de piscirickettsia salmonis et leur utilisation
CA2615139A1 (fr) * 2004-10-01 2006-04-13 Michel Thiry Antigenes de piscirickettsia salmonis et utilisation de ceux-ci

Also Published As

Publication number Publication date
US7811583B2 (en) 2010-10-12
WO2009077577A3 (fr) 2009-09-24
EP2231698B1 (fr) 2014-07-30
WO2009077577A2 (fr) 2009-06-25
AU2008337440B2 (en) 2013-05-02
CA2708167C (fr) 2016-11-29
US20110070256A1 (en) 2011-03-24
CA2708167A1 (fr) 2009-06-25
EP2231698A2 (fr) 2010-09-29
AU2008337440A1 (en) 2009-06-25
EP2231698B9 (fr) 2014-10-29
US20090162391A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
DK200801818A (en) Vaccine antigens from piscirickettsia salmonis
DK179920B1 (en) Nucleic acid sequences of a fish virus and its use
CN107529534A (zh) 一种副鸡禽杆菌的保护性抗原、及其表达和应用
US20150306209A1 (en) CANINE PARVOVIRUS TYPE 2c ISOLATES AND METHODS OF USE
DK202470172A1 (en) Compositions and methods for prevention of piscine myocarditis
CN104119441B (zh) 牛a型口蹄疫广谱多表位疫苗及其制备方法和应用
DK180623B1 (en) Fish virus
Tan et al. Cloning, expression and protective capacity of 37 kDa outer membrane protein gene (ompH) of Pasteurella multocida serotype B: 2.
Zhou et al. A novel multivalent vaccine based on secretary antigen-delivery induces protective immunity against Vibrio anguillarum and Aeromonas hydrophila
CN101880647A (zh) 重组猪霍乱沙门氏菌及二价基因工程疫苗与应用
EP1523497B1 (fr) Gene hsp70 provenant du genre arthrobacter
Meir et al. Immune responses to mucosal vaccination by the recombinant S1 and N proteins of infectious bronchitis virus
JP2025501740A (ja) ワクチンにおけるアジュバントとしてのインターフェロンの使用
CN108822192A (zh) 一种胸膜肺炎放线杆菌免疫保护性抗原蛋白apjl_1976及其应用
KR101765394B1 (ko) 돼지 유행성설사 바이러스의 에피토프 단백질, 이를 암호화하는 유전자를 포함하는 재조합 벡터, 이를 발현하는 형질전환체 및 이를 포함하는 돼지 유행성설사 바이러스 예방 또는 치료용 조성물
CN107625960A (zh) 一种通用型猪大肠杆菌病疫苗及其制备方法
DK200900603A (da) Piscirickettsia salmonis-antigener og anvendelse deraf
CN108840913A (zh) 一种胸膜肺炎放线杆菌免疫保护性抗原蛋白apjl_0922及其应用
KR102451412B1 (ko) 세포성, 체액성 면역 반응의 동시 유도 및 광범위한 방어능을 갖는 신규 면역 증강용 단백질 및 이를 포함하는 구제역 백신 조성물
DK200700656A (da) Piscirickettsia salmonis-antigener og anvendelse deraf
RU2707129C2 (ru) СПОСОБ ПОЛУЧЕНИЯ ШТАММА Е. coli BL21 Star™(DE3) pET302/NT-His tcpA - ПРОДУЦЕНТА РЕКОМБИНАНТНОГО БЕЛКА Тср А ХОЛЕРНОГО ВИБРИОНА БИОВАРА ЭЛЬ ТОР
CN107245105B (zh) HN-VP233-221aa融合蛋白及其制备方法和应用
CN104357458A (zh) 一种重组副猪嗜血杆菌免疫保护性抗原PotD及其制备方法
RU2842174C2 (ru) Композиции и способы профилактики миокардита рыб
WO2023122523A1 (fr) Compositions et méthodes d'expression antigéniques sur une membrane cellulaire

Legal Events

Date Code Title Description
PHB Application deemed withdrawn due to non-payment or other reasons

Effective date: 20140624